本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Eledon Pharmaceuticals, Inc.

3.10
0.0000
盤後3.130.0300+0.97%19:27 EDT
成交量:97.11萬
成交額:301.28萬
市值:2.35億
市盈率:-5.57
高:3.18
開:3.10
低:3.07
收:3.10
52周最高:4.60
52周最低:1.35
股本:7,585.17萬
流通股本:6,858.32萬
量比:0.80
換手率:1.42%
股息:- -
股息率:- -
每股收益(TTM):-0.5566
每股收益(LYR):-0.5566
淨資產收益率:-35.79%
總資產收益率:-30.04%
市淨率:1.72
市盈率(LYR):-5.57

資料載入中...

2022/01/28

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/26

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/13

重要事件披露

8-K - Current report
2022/01/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/08/19

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/07/09

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/07/02

重要事件披露

8-K - Current report
2021/06/16

重要事件披露

8-K - Current report
2021/05/18

SEC問詢函

CORRESP [Cover] - Correspondence
2021/05/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/04/27

重要事件披露

8-K - Current report
2021/04/12

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/31

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/15

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals